Showing results (221-230 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|March 30, 2000
Tolerability of atypical antipsychoticsC Stanniland, D Taylor
Drug Safety|December 20, 1999
A risk-benefit assessment of intra-articular corticosteroids in rheumatic disordersJ A Hunter, T H Blyth
Drug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonald
Drug Safety|February 15, 2000
Patient-oriented strategies for the prevention of drug interactionsC P Alderman
Drug Safety|February 15, 2000
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and managementS B Patten, C I Neutel
Drug Safety|February 15, 2000
Managing the adverse effects of interferon-beta therapy in multiple sclerosisA Bayas, P Rieckmann
Drug Safety|July 29, 2000
Should patients be given an initial low test dose of sildenafil?J S Cohen
Drug Safety|July 29, 2000
Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?G M Behrens, M Stoll, R E Schmidt
Drug Safety|October 29, 2000
Drug-induced rheumatic disorders: incidence, prevention and managementP Vergne, P Bertin, C Bonnet, et al.
Drug Safety|October 29, 2000
A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitisS M Gawchik, C L Saccar
Pageof 308